Kallikreins (KLKs) are a family of serine proteases responsible for many physiological functions in mammals. Of the various family members, KLK1 is well studied and found to be highly conserved among mammalian species. Aberrant gene expression of proteins in the KLK family was linked to asthma, hyperkalemia, artery dysfunction, and many other diseases (Prassas, Eissa, Poda, & Diamandis, 2015) . KLK2-15 are known as kallikrein-related peptidases, which are expressed in a wide range of tissues with specialized roles. In rodents, an evolutionary gene duplication resulted in insertion of 13 additional gene-encoding KLK1-related peptidase subfamily members (Klk1b1-27) between Klk1 and Klk15 loci (Olsson & Lundwall, 2002) .
In the uterus, the expression of Klk1 and its subfamily members are estrogen (E 2 )-dependent. Accordingly, our previous work showed that Klk1b5 is expressed at the highest level compared to other Klk members in the mouse uterus after E 2 treatment (Li, Garcia, Gewiss, & Winuthayanon, 2017) . However, the physiological function of Klk1b5 has never been investigated. As such, we generated a loss-of-function mouse model using CRISPR/Cas9 technology to determine the biological function of Klk1b5. A single-guide RNA was generated to target the beginning of the mature peptide coding sequence of exon 2 of the Klk1b5 gene ( Figure 1a) . As a result, a 19 base pairs (bp) deletion was introduced to the 5′ end of exon 2, causing a frameshift mutation ( Figure 1a 
